Oric Pharmaceuticals IncNASDAQ:ORIC
- LAST PRICE10.3000
- TODAY'S CHANGE (%)0.0400 (0.3899%)
- Bid / Lots4.1800/ 2
- Ask / Lots11.0000/ 46
- Open / Previous Close10.4300 / 10.2600
- Day Range
- 52 Week Range
- Volume371,448
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ORIC |
|---|---|---|
| 09:32 ET | 4244 | 10.49 |
| 09:33 ET | 200 | 10.485 |
| 09:37 ET | 800 | 10.52 |
| 09:39 ET | 500 | 10.32 |
| 09:42 ET | 800 | 10.42 |
| 09:46 ET | 300 | 10.34 |
| 09:48 ET | 6598 | 10.355 |
| 09:50 ET | 100 | 10.24 |
| 09:51 ET | 1314 | 10.285 |
| 09:55 ET | 200 | 10.43 |
| 09:57 ET | 400 | 10.45 |
| 10:00 ET | 1100 | 10.36 |
| 10:06 ET | 200 | 10.35 |
| 10:08 ET | 168 | 10.3463 |
| 10:13 ET | 500 | 10.35 |
| 10:18 ET | 1431 | 10.31 |
| 10:20 ET | 767 | 10.3 |
| 10:26 ET | 1437 | 10.34 |
| 10:27 ET | 500 | 10.31 |
| 10:29 ET | 154 | 10.32 |
| 10:31 ET | 1100 | 10.285 |
| 10:36 ET | 200 | 10.255 |
| 10:38 ET | 500 | 10.28 |
| 10:40 ET | 1400 | 10.28 |
| 10:42 ET | 791 | 10.23 |
| 10:45 ET | 756 | 10.21 |
| 10:47 ET | 479 | 10.21 |
| 10:51 ET | 218 | 10.23 |
| 10:54 ET | 1131 | 10.29 |
| 10:58 ET | 100 | 10.32 |
| 11:00 ET | 555 | 10.28 |
| 11:02 ET | 400 | 10.27 |
| 11:07 ET | 500 | 10.33 |
| 11:09 ET | 1850 | 10.33 |
| 11:12 ET | 320 | 10.31 |
| 11:14 ET | 200 | 10.32 |
| 11:16 ET | 200 | 10.28 |
| 11:18 ET | 120 | 10.2746 |
| 11:25 ET | 1076 | 10.345 |
| 11:27 ET | 207 | 10.34 |
| 11:30 ET | 200 | 10.345 |
| 11:32 ET | 2402 | 10.425 |
| 11:34 ET | 100 | 10.445 |
| 11:38 ET | 500 | 10.3932 |
| 11:39 ET | 200 | 10.44 |
| 11:41 ET | 258 | 10.44 |
| 11:43 ET | 100 | 10.435 |
| 11:45 ET | 700 | 10.415 |
| 11:52 ET | 100 | 10.36 |
| 11:56 ET | 500 | 10.32 |
| 11:57 ET | 100 | 10.32 |
| 11:59 ET | 1709 | 10.38 |
| 12:03 ET | 300 | 10.39 |
| 12:06 ET | 100 | 10.395 |
| 12:08 ET | 434 | 10.395 |
| 12:10 ET | 100 | 10.4 |
| 12:12 ET | 100 | 10.405 |
| 12:15 ET | 1102 | 10.37 |
| 12:26 ET | 200 | 10.315 |
| 12:30 ET | 100 | 10.28 |
| 12:32 ET | 453 | 10.31 |
| 12:33 ET | 300 | 10.32 |
| 12:35 ET | 510 | 10.36 |
| 12:37 ET | 200 | 10.355 |
| 12:39 ET | 535 | 10.35 |
| 12:42 ET | 156 | 10.35 |
| 12:46 ET | 200 | 10.355 |
| 12:48 ET | 137 | 10.345 |
| 12:50 ET | 1800 | 10.29 |
| 12:51 ET | 2833 | 10.215 |
| 12:53 ET | 548 | 10.23 |
| 12:57 ET | 600 | 10.235 |
| 01:00 ET | 1042 | 10.29 |
| 01:02 ET | 300 | 10.28 |
| 01:04 ET | 100 | 10.275 |
| 01:08 ET | 400 | 10.28 |
| 01:09 ET | 200 | 10.265 |
| 01:11 ET | 100 | 10.28 |
| 01:15 ET | 889 | 10.26 |
| 01:20 ET | 335 | 10.23 |
| 01:22 ET | 348 | 10.24 |
| 01:24 ET | 100 | 10.25 |
| 01:26 ET | 2799 | 10.29 |
| 01:27 ET | 100 | 10.31 |
| 01:29 ET | 900 | 10.36 |
| 01:31 ET | 759 | 10.355 |
| 01:36 ET | 358 | 10.39 |
| 01:38 ET | 237 | 10.4 |
| 01:44 ET | 1448 | 10.38 |
| 01:49 ET | 300 | 10.39 |
| 01:51 ET | 200 | 10.37 |
| 01:58 ET | 200 | 10.39 |
| 02:02 ET | 735 | 10.41 |
| 02:03 ET | 862 | 10.37 |
| 02:05 ET | 172 | 10.37 |
| 02:12 ET | 100 | 10.37 |
| 02:14 ET | 149 | 10.37 |
| 02:18 ET | 100 | 10.36 |
| 02:20 ET | 100 | 10.35 |
| 02:21 ET | 200 | 10.36 |
| 02:23 ET | 100 | 10.34 |
| 02:25 ET | 265 | 10.34 |
| 02:27 ET | 100 | 10.34 |
| 02:32 ET | 300 | 10.32 |
| 02:34 ET | 848 | 10.36 |
| 02:36 ET | 300 | 10.35 |
| 02:39 ET | 100 | 10.33 |
| 02:41 ET | 200 | 10.33 |
| 02:43 ET | 451 | 10.35 |
| 02:45 ET | 100 | 10.34 |
| 02:52 ET | 200 | 10.36 |
| 02:54 ET | 500 | 10.35 |
| 02:56 ET | 200 | 10.34 |
| 02:59 ET | 100 | 10.35 |
| 03:03 ET | 200 | 10.33 |
| 03:08 ET | 457 | 10.36 |
| 03:10 ET | 200 | 10.38 |
| 03:12 ET | 400 | 10.415 |
| 03:14 ET | 300 | 10.4 |
| 03:17 ET | 100 | 10.39 |
| 03:19 ET | 419 | 10.39 |
| 03:21 ET | 900 | 10.36 |
| 03:24 ET | 346 | 10.38 |
| 03:30 ET | 400 | 10.38 |
| 03:32 ET | 200 | 10.38 |
| 03:35 ET | 802 | 10.41 |
| 03:39 ET | 28492 | 10.4 |
| 03:42 ET | 300 | 10.385 |
| 03:44 ET | 1570 | 10.38 |
| 03:46 ET | 600 | 10.38 |
| 03:48 ET | 1219 | 10.35 |
| 03:50 ET | 2457 | 10.33 |
| 03:51 ET | 2196 | 10.37 |
| 03:53 ET | 1000 | 10.35 |
| 03:55 ET | 1406 | 10.315 |
| 03:57 ET | 2807 | 10.33 |
| 04:00 ET | 154845 | 10.3 |
Nov 4, 2024
ORIC(R) Pharmaceuticals to Participate in Upcoming Investor Conferences, from 4:15PM ET on Monday Nov 04, 2024 by Dow Jones
4:15PM ET on Monday Nov 04, 2024 by Dow JonesDJ Oric Pharmaceuticals Price Target Maintained With a $21.00/Share by HC Wainwright & Co., from 7:04AM ET on Monday Nov 04, 2024 by Dow Jones
7:04AM ET on Monday Nov 04, 2024 by Dow Jones
Nov 1, 2024
ORIC(R) Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4), from 4:30PM ET on Friday Nov 01, 2024 by Dow Jones
4:30PM ET on Friday Nov 01, 2024 by Dow Jones
Oct 31, 2024
DJ Oric Pharmaceuticals Initiated at Overweight by Wells Fargo, from 3:52PM ET on Thursday Oct 31, 2024 by Dow Jones
3:52PM ET on Thursday Oct 31, 2024 by Dow JonesDJ Oric Pharmaceuticals Initiated at Buy by Jones Trading, from 7:18AM ET on Thursday Oct 31, 2024 by Dow Jones
7:18AM ET on Thursday Oct 31, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Oric Pharmaceuticals Inc | 723.8M | -5.8x | --- |
Humacyte Inc | 722.7M | -4.4x | --- |
MBX Biosciences Inc | 729.8M | -15.9x | --- |
Tourmaline Bio Inc | 737.4M | -11.2x | --- |
Olema Pharmaceuticals Inc | 710.1M | -6.2x | --- |
Mineralys Therapeutics Inc | 698.2M | -5.5x | --- |
Company Information
ORIC Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaged in improving patients' lives by overcoming resistance in cancer. It is developing a pipeline of clinical and discovery stage therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology and key tumor dependencies. Its clinical-stage product candidates include ORIC-114, a brain penetrant inhibitor designed to selectively target EGFR and HER2 with high potency against exon 20 insertion mutations, being developed across multiple genetically defined cancers, ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 (PRC2) via the EED subunit, being developed for prostate cancer, and ORIC-533, an orally bioavailable small molecule inhibitor of CD73, a key node in the adenosine pathway believed to play a central role in resistance to chemotherapy- and immunotherapy-based treatment regimens.
Contact Information
- Headquarters
- 240 E. Grand Ave, 2nd FloorSOUTH SAN FRANCISCO, CA, United States 94080
- Phone
- 650-388-5600
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Richard Heyman
- President, Chief Executive Officer, Director
- Jacob Chacko
- Chief Financial Officer
- Dominic Piscitelli
- Chief Medical Officer
- Pratik Multani
- Independent Director
- Mardi Dier
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $723.8M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 70.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.13 |
EPS | $-1.76 |
Book Value | $4.08 |
P/E Ratio | -5.8x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
